The Koebner phenomenon seen in a case of drug-induced granular C3 dermatosis.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and experimental dermatology"
DOI: 10.1111/ced.14977
Abstract: Granular C3 dermatosis (GCD), first described by Hashimoto et al. in 2016, is characterised by granular deposition of C3 and C5b-9, but not immunoglobulin (Ig)A, IgG or IgM, at the epidermal basement membrane zone (BMZ)… read more here.
Keywords: seen case; koebner phenomenon; case drug; granular dermatosis ... See more keywords
First case of drug‐induced liver injury associated with the use of tocilizumab in a patient with COVID‐19
Sign Up to like & getrecommendations! Published in 2020 at "Liver International"
DOI: 10.1111/liv.14516
Abstract: Tocilizumab (TCZ; interleukine‐6 receptor antagonist) has been proposed to treat severe forms of Coronavirus disease‐19 (COVID‐19) because interleukine‐6 plays an important role in COVID‐19‐induced cytokine storm. Several clinical studies have shown very good effects of… read more here.
Keywords: use; case drug; drug induced; first case ... See more keywords
Case of drug eruption during treatment with lithium and lamotrigine implicating a possible role of additives in the lithium tablet
Sign Up to like & getrecommendations! Published in 2019 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.12834
Abstract: Lithium treatment causes drug eruptions in a few patients. Mohandas and Rajmohan1 suggest that acneiform eruptions, psoriasis, maculopapular eruptions, and follicular eruptions are the most common cutaneous reactions to lithium. This article is protected by… read more here.
Keywords: treatment; case drug; eruption treatment; lithium ... See more keywords